Bio-Gene Technology Limited (BGT.AX)
AUD 0.04
(0.0%)
AUD 0.04
(0.0%)
| Breakdown | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | -2.75 Million | -3.27 Million | 43.51 Thousand | -1.82 Million | -1.64 Million | -2.2 Million |
| Net Income | -2.4 Million | -3.09 Million | -2.91 Million | -2.39 Million | -1.93 Million | -2.05 Million |
| Depreciation & Amortization | 38.38 Thousand | 45.29 Thousand | 43.51 Thousand | 54.22 Thousand | 58.43 Thousand | 45.55 Thousand |
| Deferred income taxes | - | -499.2 Thousand | -798.44 Thousand | -335.88 Thousand | -633.33 Thousand | -510.79 Thousand |
| Stock-based compensation | - | 48.65 Thousand | 453 Thousand | 367.53 Thousand | 325.71 Thousand | 96.55 Thousand |
| Change in working capital | -383.44 Thousand | -281.3 Thousand | 388.95 Thousand | 109.78 Thousand | -197.17 Thousand | -360.76 Thousand |
| Other non-cash items | 400.72 Thousand | 505.98 Thousand | 2.87 Million | 375.07 Thousand | 734.76 Thousand | 583.53 Thousand |
| Investing Cash Flow | -5698.00 | - | -6840.00 | -3029.00 | - | -6882.00 |
| Investments in PPE | -5698.00 | - | -6840.00 | -3029.00 | - | -2682.00 |
| Acquisitions | - | - | - | - | - | - |
| Investment purchases | - | - | - | - | - | - |
| Sales/Maturities of investments | - | - | - | - | - | - |
| Other Investing Activities | - | - | - | - | - | -4200.00 |
| Financing Cash Flow | 1.97 Million | -75 Thousand | 4.4 Million | 239.87 Thousand | 2.66 Million | 1173.00 |
| Debt repayment | - | -75 Thousand | -75 Thousand | -11.66 Thousand | -13.76 Thousand | - |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | -55.15 Thousand | - | -235.82 Thousand | -21.05 Thousand | -147.63 Thousand | - |
| Common Stock Issuance | 1.97 Million | - | 4.71 Million | 272.6 Thousand | 2.82 Million | 1173.00 |
| Other Financing Activities | 1.97 Million | -75 Thousand | 75 Thousand | 11.66 Thousand | 13.76 Thousand | 1173.00 |
| Accounts receivables | -99.45 Thousand | -7382.00 | 85.58 Thousand | -40.71 Thousand | -10.27 Thousand | -104.4 Thousand |
| Accounts payables | -224.5 Thousand | -352.57 Thousand | 319.34 Thousand | 180.8 Thousand | -180.47 Thousand | -218.72 Thousand |
| Inventory | - | - | - | - | - | - |
| Other working capital | -59.48 Thousand | 78.65 Thousand | -15.97 Thousand | -30.31 Thousand | -6425.00 | -37.63 Thousand |
| Cash at beginning of period | 2.99 Million | 6.34 Million | 3.93 Million | 5.52 Million | 4.49 Million | 6.7 Million |
| Cash at end of period | 709.55 Thousand | 2.99 Million | 6.34 Million | 3.93 Million | 5.52 Million | 4.49 Million |
| Capital Expenditure | -5698.00 | - | -6840.00 | -3029.00 | - | -2682.00 |
| Effect of forex changes on cash | - | - | -2.03 Million | - | - | - |
| Net cash flow / Change in cash | -2.28 Million | -3.35 Million | 2.4 Million | -1.58 Million | 1.02 Million | -2.2 Million |
| Free Cash Flow | -2.75 Million | -3.27 Million | 36.67 Thousand | -1.82 Million | -1.64 Million | -2.2 Million |
| Breakdown | 2024 FY | 2024 Q4 | 2024 Q2 | 2023 Q4 | 2023 FY | 2023 Q2 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | -2.4 Million | -899.96 Thousand | -1.5 Million | -1.12 Million | -3.09 Million | -1.97 Million |
| Depreciation & Amortization | 38.38 Thousand | 16.22 Thousand | 22.15 Thousand | 22.45 Thousand | 45.29 Thousand | 22.83 Thousand |
| Deferred income taxes | - | - | - | -61.86 Thousand | -499.2 Thousand | - |
| Stock-based compensation | - | - | - | 24.32 Thousand | 48.65 Thousand | 24.32 Thousand |
| Change in working capital | -383.44 Thousand | -158.94 Thousand | - | 71.27 Thousand | -281.3 Thousand | - |
| Other non-cash items | 400.72 Thousand | 33.37 Thousand | -257.87 Thousand | -42.86 Thousand | 505.98 Thousand | -162.41 Thousand |
| Investing Cash Flow | -5698.00 | -8098.00 | 2400.00 | - | - | - |
| Investments in PPE | -5698.00 | -3898.00 | -1800.00 | - | - | - |
| Acquisitions | - | - | - | - | - | - |
| Investment purchases | - | - | - | - | - | - |
| Sales/Maturities of investments | - | - | - | - | - | - |
| Other Investing Activities | - | -4200.00 | 4200.00 | - | - | - |
| Financing Cash Flow | 1.97 Million | - | 1.97 Million | -75 Thousand | -75 Thousand | - |
| Debt repayment | - | - | - | - | -75 Thousand | - |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | 1.97 Million | - | 1.97 Million | - | - | - |
| Other Financing Activities | - | - | 1.97 Million | -75 Thousand | -75 Thousand | - |
| Accounts receivables | -99.45 Thousand | -99.45 Thousand | - | -7382.00 | -7382.00 | - |
| Accounts payables | -224.5 Thousand | - | - | - | -352.57 Thousand | - |
| Inventory | - | - | - | - | - | - |
| Other working capital | -59.48 Thousand | -59.48 Thousand | - | 78.65 Thousand | 78.65 Thousand | - |
| Cash at beginning of period | 2.99 Million | 3.22 Million | 2.99 Million | 4.25 Million | 6.34 Million | 6.34 Million |
| Cash at end of period | 709.55 Thousand | 2.2 Million | 3.22 Million | 2.99 Million | 2.99 Million | 4.25 Million |
| Capital Expenditure | -5698.00 | -3898.00 | -1800.00 | - | - | - |
| Effect of forex changes on cash | - | - | -1.5 Million | - | - | - |
| Net cash flow / Change in cash | -2.28 Million | -1.01 Million | 236.43 Thousand | -1.26 Million | -3.35 Million | -2.08 Million |
| Free Cash Flow | -2.75 Million | -1.01 Million | -1.74 Million | -1.19 Million | -3.27 Million | -2.08 Million |
DIS
006890
0939
600051
ORXGF
NOA